Impact of autoSCT, alloSTC, and GO administration in CBF-AML patients after relapse. Plots by Simon and Makuch for DFS and OS in nonallogeneic transplanted patients (N = 67) according to autoSCT. (A) For the whole cohort of patients according to allogeneic transplantation and (B) in allogeneic transplanted patients (N = 77) according to GO administration before transplant (C).